- Q1 0 —
- Q2 0 —
- Q3 0 —
- Q4 0 —
Academician
HAKAN ÇAVUŞ
Doktor Öğretim Üyesi
İstanbul Okan Üniversitesi Tıp Fakültesi Dahili Tıp Bilimleri Bölümü
Academic summary
YÖKSİS and OpenAlex counted separately.
Articles
0
YÖKSİS0
OpenAlex0
Projects
0
Books
0
Proceedings
0
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 0 + YÖKSİS · co-author record: 4
h-index
4
- i10-index
- 4
- Total citations
- 1,010
- Per article
- 252.5
- FWCI
- 9.63 1.00 = world average
- World top 1%
- 1
- World top 10%
- 3
Most cited articles
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
- ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab
- Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 4 articles (1,010 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.
Index quartiles
?- Q1 0 —
- Q2 0 —
- Q3 0 —
- Q4 0 —
Projects
Research and development projects recorded in YÖKSİS.
Records
No records in this section.